Login / Signup

Type 2 diabetes remission: economic evaluation of the DiRECT/Counterweight-Plus weight management programme within a primary care randomized controlled trial.

Yiqiao XinA DaviesL McCombieA BriggsC-M MessowE GrieveW S LeslieR TaylorM E J Lean
Published in: Diabetic medicine : a journal of the British Diabetic Association (2020)
Remission of Type 2 diabetes within 1-year can be achieved at a cost below the annual cost of diabetes (including complications). Providing a reasonable proportion of remissions can be maintained over time, with multiple medical gains expected, as well as immediate social benefits, there is a case for shifting resources within diabetes care budgets to offer support for people with Type 2 diabetes to attempt remission. (Clinical Trial Registry No.: ISRCTN03267836).
Keyphrases